Bristol-Myers Squibb has recalled one lot of its warfarin sodium product because of the possibility the tablets might contain doses that are too high.

Bris﻿tol-Myers Squibb has recalled one lot of its warfarin sodium product because of the possibility the tablets might contain doses that are too high.

The recall applies to Coumadin Crystalline 5 mg tablets -- lot number 9H49374A -- in 1,000 count bottles, which are distributed to pharmacies for dispensing to customers in prescription quantities. The bottles carry a Sept. 30, 2012 expiration date.

In a press release, the company said testing of a returned bottle identified a single tablet that had higher-than-expected potency. Taking too much of the anticoagulant could increase bleeding.

"Patients who may have 5 mg tablets should not interrupt their therapy but should seek advice from their pharmacist to see if they have tablets originating from the affected lot and, if so, should consult their physician for appropriate medical advice," the release stated.

There was a similar issue earlier this year when Upsher-Smith Laboratories recalled some of its generic warfarin product (Jantoven) because of the possibility of tablets with the wrong doses.